Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages

Abstract

Taken together, our results show that melanoma-specific bcl-2 controls an IL-1β-driven axis of macrophage diversion that establishes tumor microenvironmental conditions favoring melanoma development. Interfering with this pathway might provide novel therapeutic strategies.